Skip to content
Screener

Total Revenue at other companies

CareDx logo
CareDxCDNA
$117.7M+39.0%
LivaNova logo
LivaNovaLIVN
$390.59M+10.8%
SRT
Strata Critical MedicalSRTA
$67.38M+87.4%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
$32K-98.5%
ICU Medical logo
ICU MedicalICUI
$551.68M+0.5%
Stereotaxis logo
StereotaxisSTXS
$6.29M-15.8%

Segments

By product

See full
Liver Product$138.98M+27.7%
Heart Product$30.87M+3.5%
Lung Product$2.82M-29.6%

By segment

See full
Ocs Transplant Revenue$172.67M+21.0%

By geography

See full
Non Us$5.65M

Other financials

Income statement

See full
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.78B-31.3%
Enterprise value$2.73B-26.6%
P/E16.2×-40.3×
P/S4.4×-3.2×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206453
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue:
Net product revenue$107,972$88,234
Service revenue65,96155,303
Total revenue173,933143,537
Cost of revenue:
Cost of net product revenue24,30816,312
Cost of service revenue48,46438,997
Total cost of revenue72,77255,309

Item 1. Financial Statements (Unaudited)

FAQ

What is TransMedics Group, Inc.'s total revenue?
TransMedics Group, Inc. (TMDX) reported total revenue of $173.93M in Q1 2026.
How has TransMedics Group, Inc.'s total revenue changed year-over-year?
TransMedics Group, Inc.'s total revenue increased by 21.2% year-over-year, from $143.54M to $173.93M.
What is the long-term trend for TransMedics Group, Inc.'s total revenue?
Over 4 years (2021 to 2025), TransMedics Group, Inc.'s total revenue has grown at a 111.5% compound annual growth rate (CAGR), from $30.26M to $605.49M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about TransMedics Group, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude